The USPSTF call to inaction on blood pressure screening in children and adolescents

被引:0
作者
Bonita Falkner
Empar Lurbe
机构
[1] Thomas Jefferson University,Departments of Medicine and Pediatrics
[2] University of Valencia,undefined
来源
Pediatric Nephrology | 2021年 / 36卷
关键词
Blood pressure; Hypertension; Children; Adolescents;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1327 / 1329
页数:2
相关论文
共 164 条
  • [1] Moyer VA(2020)Screening for high blood pressure in children and adolescents: US Preventive Services Task Force recommendation statement JAMA 324 1878-1883
  • [2] Gartlehner GVSE(2013)Screening for primary hypertension in children and adolescents: US Preventive Services Task Force recommendation statement Pediatrics 132 907-914
  • [3] Orr C(2020)Screening for hypertension in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force JAMA 324 1884-1895
  • [4] Kennedy SM(2017)Clinical practice guideline for screening and management of high blood pressure in children and adolescents Pediatrics 140 e220171904-1920
  • [5] Clark R(2016)2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents J Hypertens 34 1887-597
  • [6] Viswanathan M(2016)Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, and assessment of risk of pediatric hypertension Can J Cardiol 32 589-224
  • [7] Flynn JT(2013)Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium Circulation 128 217-1223
  • [8] Kaelber DC(2019)2017 pediatric hypertension guidelines improve prediction of adult cardiovascular outcomes Hypertension 73 1217-209
  • [9] Baker-Smith CM(2010)Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers Hypertension 56 203-1115
  • [10] Blowey D(2015)Childhood to early-midlife systolic blood pressure trajectories: early-life predictors, effect modifiers, and adult cardiovascular outcomes Hypertension 66 1108-955